Latest S-1 registration statements

FibroBiologics is launching a best-efforts offering of up to 1,801,801 units, each comprising a share of common stock and a warrant, to raise capital for research, development, and general corporate purposes.

Sonnet BioTherapeutics is seeking to raise up to $25 million through a committed equity facility with Chardan Capital Markets, potentially diluting existing shareholders.

Applied DNA Sciences aims to raise capital to further develop its Therapeutic DNA Production and MDx Testing Services through a public offering of common stock, warrants, and pre-funded warrants.

Lionsgate Studios Corp. files an amendment for the resale of up to 26.2 million common shares by selling shareholders following a business combination.

Cardiff Lexington Corporation files an amended registration statement for a proposed offering of 1,600,000 shares of common stock, contingent upon uplisting to NYSE American or Nasdaq.

Kaival Brands Innovations Group, Inc. is launching a best efforts offering of units and pre-funded units to raise up to $5 million, as detailed in its S-1/A filing, while navigating a complex regulatory landscape for ENDS products.

Korro Bio is registering the resale of up to 1,213,569 shares of its common stock by selling stockholders, with the company not receiving any proceeds from the sale.

AgEagle Aerial Systems files an amendment to its S-1 registration statement, covering the resale of up to 5,470,760 shares of common stock by selling shareholders.

Lakeside Holding Limited has filed Amendment No. 2 to its Form S-1 registration statement with the SEC, pertaining to its initial public offering of common stock.

LGAC International LLC and Lions Gate Capital Holdings 1, Inc. enter into a bi-directional revolving credit facility agreement with a borrowing limit of $150 million.

AtlasClear Holdings has filed a registration statement for the potential resale of up to 37,885,852 shares of its common stock by selling stockholders.

Aditxt, Inc. files an amendment to its S-1 registration statement, detailing the potential resale of 3,785,569 shares of common stock by a selling stockholder and the possibility of generating $12.3 million through warrant exercises.

Scorpius Holdings has filed a registration statement to register $1.38 million in shares of common stock issuable upon the exercise of warrants.

Cheetah Net Supply Chain Service Inc. is registering an additional 3,210,000 shares of Class A common stock via Form S-1MEF, supplementing a previous registration to increase the aggregate offering.

Jet.AI Inc. has filed a registration statement for the resale of up to 12.2 million shares of its common stock by a selling stockholder.

Virpax Pharmaceuticals is launching a best efforts offering of common stock and warrants, aiming to raise approximately $4.4 million for working capital and general corporate purposes.

Aethlon Medical launches a best-efforts offering of common stock and warrants to fund research, clinical trials, and general corporate activities.

Heritage Distilling Holding Company seeks to go public, offering 2,000,000 shares of common stock with an estimated price range of $4.50 to $5.50 per share.

Energy and Water Development Corp. files an amendment to its registration statement for a public offering and resale of common stock, aiming for a NYSE American listing.

NKGen Biotech aims to raise capital through the potential exercise of outstanding warrants while registering the resale of a significant number of common shares by existing securityholders.

HNR Acquisition Corp files an amendment to its registration statement for the resale of up to 18.4 million shares of Class A Common Stock by selling securityholders following its business combination with Pogo Resources.

Chenghe Acquisition II Co., a blank check company, aims to raise $75 million through an IPO to pursue business combinations with growing companies in Asian markets or global companies with an Asian focus.

First Choice Healthcare Solutions aims to raise capital through an IPO to transition from orthopedics to a national chain of primary care and wellness clinics.

Bowhead Specialty Holdings Inc. finalizes a registration rights agreement and prepares for its initial public offering, detailing terms for key investors.

Kenvue Inc. files an S-1 registration statement for a secondary offering of 182,329,550 shares of common stock, as Johnson & Johnson plans to fully divest its remaining stake through a debt-for-equity exchange.

Scorpius Holdings launches a firm commitment public offering of units and pre-funded units to raise capital for working capital, general corporate purposes and the repayment of debt.

Kairos Pharma, a clinical-stage biopharmaceutical company, is seeking to raise $6.2 million through an initial public offering to advance its cancer therapeutics pipeline and list its common stock on the NYSE American under the symbol KAPA.

Abacus Life, a longevity-focused alternative asset manager, has filed a registration statement for a common stock offering to support its operations, business strategy, and working capital needs.

ENDRA Life Sciences launches an offering of common stock and warrants, aiming to raise approximately $4.3 million for working capital and general corporate purposes.

CervoMed is registering the resale of approximately 5.1 million shares of its common stock following a recent private placement.